Molecular imaging fundamentally changes the way we look at cancer. Imaging paradigms
are now shifting away from classical morphological measures towards the assessment of …

Researchers have made great progress in defining genetic and molecular alterations that
contribute to cancer. New therapeutic targets have been identified and targeted therapeutic …

Over the past decades, imaging in oncology has been undergoing a “quiet” revolution to
treat images as data, not as pictures. This revolution has been sparked by technological …

During the past ten years, positron emission tomography (PET) has been increasingly
developed for imaging and quantifying molecular mechanisms in oncology. The technique …

Over recent years, there has been a rapid expansion in our knowledge of the factors that
regulate tumor growth; this has resulted in the identification of new therapeutic targets and …

Purpose Improvements in personalized therapy are made possible by the advances in
molecular biology that led to developments in molecular imaging, allowing highly specific in …

Abstract Purpose of Review We present an overview of recent advances in positron
emission tomography (PET) diagnostics as applied to the study of cancer, specifically as a …

Imaging has become an indispensable tool in the study of cancer biology and in clinical
prognosis and treatment. The rapid advances in high resolution fluorescent imaging at …

The success of cancer therapy can be difficult to predict, as its efficacy is often predicated
upon characteristics of the cancer, treatment, and individual that are not fully understood or …

A recent volume of Molecular Imaging and Biology includes a report of a workshop on
preclinical and clinical positron emission tomography (PET)/magnetic resonance imaging …